UNSPSC 51334003: Spirilene

This classification denotes a dopamine antagonist with the molecular formula C24H28FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 672229USCQ, chemically known as 1,3,8-triazaspiro(4.5)decan-4-one, 8-(4-(p-fluorophenyl)-3-penenyl)-1-phenyl- but generally known as spirilene, which bears US NIH Compound Identifier 6436870. European Medicines Agency schedules Spirilene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10625MIG. The term SPIRILENE is an International Non-Proprietary Name.

UNSPSC 51334003 Spirilene, a Commodity code, does not align with the state and local procurement activity currently tagged under it. The three recent opportunities in the record—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's Request for Information on direct-to-manufacturer prescriptions, and MMCAP's multi-state cooperative purchasing agreement for generic pharmaceuticals and OTC products—all involve pharmaceutical supply, pharmacy benefit management, or drug distribution. None of these solicitations reference spirilene or any products matching the code's nominal scope. The mismatch between the code name and the actual work being bought suggests either a cataloging error in the source data or that spirilene is not a meaningful procurement category in state and local government contracting at present.

State and local buying bodies—including county health departments, state health and human services agencies, and multi-state cooperative purchasing alliances—are actively procuring pharmaceuticals, naloxone, drug deactivation systems, and OTC products through RFPs, RFIs, and competitive bidding processes. Recent activity spans Florida (Seminole County, IFB posted June 30, 2026 with response deadline July 26, 2023), Texas (HHS RFI posted April 3, 2026), and multi-state cooperative purchasing through Minnesota (MMCAP RFP posted January 20, 2026 with response deadline March 26, 2026, serving participating states including Oregon). However, these opportunities are not meaningfully connected to code 51334003 as currently defined. Business development professionals should verify the correct UNSPSC classification for pharmaceutical and drug-product opportunities before using this code to track procurement activity.